OPTN Logo

OptiNose, Inc. (OPTN) 

NASDAQ
Market Cap
$144.55M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
688 of 809
Rank in Industry
38 of 53

Largest Insider Buys in Sector

OPTN Stock Price History Chart

OPTN Stock Performance

About OptiNose, Inc.

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.

Insider Activity of OptiNose, Inc.

Over the last 12 months, insiders at OptiNose, Inc. have bought $0 and sold $213,255 worth of OptiNose, Inc. stock.

On average, over the past 5 years, insiders at OptiNose, Inc. have bought $277,322 and sold $9.88M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 34,000 shares for transaction amount of $104,040 was made by Clavelli Victor M (Chief Commercial Officer) on 2021‑05‑20.

List of Insider Buy and Sell Transactions, OptiNose, Inc.

2024-06-18SaleMahmoud Ramy AChief Executive Officer
18,987
0.0124%
$1.19$22,595-6.09%
2024-06-18SaleMarino Michael F IIIChief Legal Officer & Corp Sec
3,267
0.0021%
$1.19$3,888-6.09%
2024-06-18SaleMarino Michael F IIIChief Legal Officer & Corp Sec
6,213
0.0041%
$1.19$7,393-6.09%
2024-06-18SaleKrick Anthony JChief Accounting Officer
624
0.0004%
$1.19$743-6.09%
2024-03-18SaleMahmoud Ramy AChief Executive Officer
19,198
0.0166%
$1.88$36,092-40.46%
2024-03-18SaleMarino Michael F IIIChief Legal Officer & Corp Sec
15,059
0.013%
$1.88$28,311-40.46%
2024-03-18SaleKrick Anthony JChief Accounting Officer
2,345
0.002%
$1.88$4,409-40.46%
2024-01-31SaleMahmoud Ramy AChief Executive Officer
52,875
0.046%
$1.31$69,266-1.98%
2023-12-18SaleMahmoud Ramy AChief Executive Officer
11,114
0.01%
$1.15$12,781+8.70%
2023-12-18SaleMarino Michael F IIIChief Legal Officer & Corp Sec
5,005
0.0045%
$1.15$5,756+8.70%
2023-09-18SaleMahmoud Ramy AChief Executive Officer
11,083
0.0098%
$1.37$15,184-10.14%
2023-09-18SaleMarino Michael F IIIChief Legal Officer & Corp Sec
4,991
0.0044%
$1.37$6,838-10.14%
2023-06-16SaleMahmoud Ramy AChief Executive Officer
3,543
0.0031%
$1.15$4,074+6.47%
2023-06-16SaleMarino Michael F IIIChief Legal Officer & Corp Sec
1,516
0.0013%
$1.15$1,743+6.47%
2023-03-16SaleMahmoud Ramy AChief Executive Officer
11,040
0.0097%
$1.79$19,762-31.69%
2023-03-16SaleMarino Michael F IIIChief Legal Officer & Corp Sec
4,972
0.0044%
$1.79$8,900-31.69%
2023-01-13SaleMiller Peter KChief Executive Officer
29,664
0.0261%
$1.77$52,505-30.56%
2023-01-13SaleMahmoud Ramy APresident and COO
8,148
$0$0-30.56%
2023-01-13SaleMarino Michael F IIIChief Legal Officer & Corp Sec
5,241
0.0046%
$1.77$9,277-30.56%
2022-12-16SaleMiller Peter KChief Executive Officer
15,253
0.016%
$1.69$25,778-25.29%

Insider Historical Profitability

<0.0001%
Mahmoud Ramy AChief Executive Officer
1318404
0.4883%
$1.00025
Marino Michael F IIIChief Legal Officer & Corp Sec
599872
0.297%
$1.00717<0.0001%
Krick Anthony JChief Accounting Officer
143364
0.1278%
$1.0002
Miller Peter KChief Executive Officer
853384
0.7598%
$1.00617<0.0001%
Venkataraman Sriram
807995
0.7194%
$1.0002
Avista Capital Partners II GP, LLC10 percent owner
807995
0.7194%
$1.0002
Clavelli Victor MChief Commercial Officer
199955
0.178%
$1.0017<0.0001%
Goldan Keith A.Chief Financial Officer
141726
0.1262%
$1.0015<0.0001%
Janis MicheleActing Chief Financial Officer
48927
0.0436%
$1.0004
Scodari Joseph Cdirector
31230
0.0278%
$1.0040<0.0001%
O'Neil Robert Pdirector
7000
0.0062%
$1.0020<0.0001%
Gibbs Thomas EdwardChief Commercial Officer
2596
0.0023%
$1.0011<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Mvm Partners Llc$21.25M10.0814.61M0%+$013.68
Fidelity Investments$21.27M10.0614.57M-0.68%-$144,723.96<0.01
Great Point Partners$12.83M6.078.79M-0.61%-$78,286.662.15
BlackRock$6.25M2.964.28M-2.75%-$176,565.12<0.0001
The Vanguard Group$6.19M2.934.24M+1.5%+$91,842.77<0.0001
Bleichroeder Lp$5.91M2.794.05M0%+$01.56
Kingdon Capital Management$5.69M2.693.9M0%+$00.75
Velan Capital$4.38M2.073M-20.96%-$1.16M2.38
Massachusetts Financial Services Co Ma$4.15M1.962.84M-0.52%-$21,685.38<0.01
Nantahala Capital Management Llc$3.61M1.712.47M-21.37%-$982,032.460.37
Levin Easterly Partners Llc$2.98M1.412.04M+33.97%+$754,425.810.2
Geode Capital Management$2.29M1.081.57M+7.63%+$162,526.91<0.0001
State Street$1.99M0.941.36M+5.21%+$98,577.75<0.0001
Rice Hall James & Associates, LLC$1.45M0.69993,268-1.16%-$16,963.740.09
Prescott Group Capital Management LLC$1.23M0.58839,567New+$1.23M0.14
Northern Trust$905,774.000.43620,393+0.83%+$7,453.30<0.0001
Prelude Capital$525,600.000.25360,000+33.33%+$131,400.000.04
BNY Mellon$520,691.000.25356,637-7.18%-$40,263.96<0.0001
Bridgeway Capital Management$493,626.000.23338,1000%+$00.01
Millennium Management LLC$482,802.000.23330,686+180.75%+$310,832.82<0.0001
Oracle Investment Management Inc$474,500.000.22325,000New+$474,500.000.06
Marshall Wace$449,115.000.21307,613New+$449,115.00<0.01
Renaissance Technologies$412,000.000.2281,900+51.48%+$140,012.77<0.01
Charles Schwab$296,101.000.14202,8090%+$0<0.0001
Morgan Stanley$265,974.000.13182,174-23.23%-$80,488.33<0.0001
JPMorgan Chase$185,921.000.09127,343+148.27%+$111,033.13<0.0001
Goldman Sachs$182,556.000.09125,038+37.29%+$49,581.74<0.0001
Palumbo Wealth Management$173,781.000.08119,028+358.52%+$135,880.830.08
Nuveen$163,797.000.08112,1900%+$0<0.0001
Citadel Advisors LLC$151,071.000.07103,473+303.83%+$113,661.32<0.0001
Barclays$147,000.000.07100,787-32.71%-$71,452.96<0.0001
Brown Brothers Harriman Co$146,000.000.07100,0000%+$0<0.01
RhumbLine Advisers$137,356.000.0794,085+3.08%+$4,102.36<0.0001
Assenagon Asset Management S.A.$127,160.000.0687,096+139.05%+$73,966.43<0.0001
Gsa Capital Partners Llp$111,000.000.0576,010+212.34%+$75,461.310.01
UBS$106,932.000.0573,241-6.24%-$7,120.43<0.0001
Squarepoint Ops LLC$91,552.000.0462,707New+$91,552.00<0.0001
New York State Common Retirement Fund$70,000.000.0347,639-0.4%-$283.59<0.0001
MetLife Investment Management$57,168.000.0339,156New+$57,168.00<0.0001
Prudential Financial$53,202.000.0336,4400%+$0<0.0001
American International Group$52,462.000.0335,933-0.85%-$452.60<0.0001
Invesco$46,861.000.0232,097-0.85%-$400.04<0.0001
Hightower Advisors$44,000.000.0230,2350%+$0<0.0001
HSBC$44,216.000.0230,285+37.8%+$12,128.19<0.0001
Connor Clark & Lunn Investment Management Ltd$30,921.000.0221,179New+$30,921.00<0.0001
Voya Investment Management LLC$32,459.000.0222,232+63.03%+$12,548.81<0.0001
Wells Fargo$32,234.000.0222,078+15.25%+$4,264.68<0.0001
The Manufacturers Life Insurance Company$27,817.000.0119,053New+$27,817.00<0.0001
T. Rowe Price$28,000.000.0118,651+6.55%+$1,720.44<0.0001
Ground Swell Capital Llc$19,983.000.0113,687New+$19,983.000.02